Stay updated on Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.

Latest updates to the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no substantive study content changes are indicated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check29 days agoChange DetectedThe Publications section wording was updated to say PubMed-sourced publications are auto-filled from PubMed and may not pertain to the study, and the revision version changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved the government funding status notice from the page. The study details and eligibility information remain unchanged.SummaryDifference0.3%

- Check51 days agoChange DetectedNo substantive changes were detected on the Study Details page; only minor formatting or layout adjustments are visible in the screenshots, and the core study data (objectives, design, eligibility criteria, and outcomes) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check80 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

Stay in the know with updates to Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.